RetinalGenix Technologies Inc.
RTGN · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $28,705 | $53,618 | $140,259 | $42,847 |
| - Cash | $6 | $0 | $0 | $5 |
| + Debt | $57 | $507 | $49 | $73 |
| Enterprise Value | $28,755 | $54,125 | $140,308 | $42,915 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | -$0 | -$0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$4,316 | -$2,087 | -$3,909 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$4,321 | -$2,091 | -$3,914 | -$2,182 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.24 | -0.12 | -0.25 | -0.15 |
| % Growth | -100% | 52% | -66.7% | – |
| Operating Cash Flow | -$742 | -$348 | -$199 | -$1,167 |
| Capital Expenditures | -$0 | $0 | -$0 | $0 |
| Free Cash Flow | -$742 | -$348 | -$200 | -$1,167 |